Literature DB >> 12667577

Usefulness of platelet reactivity before percutaneous coronary intervention in determining cardiac risk one year later.

Samer S Kabbani1, Matthew W Watkins, Taka Ashikaga, Edward F Terrien, Burton E Sobel, David J Schneider.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12667577     DOI： 10.1016/s0002-9149(03)00025-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  11 in total

1.  PGE2 decreases reactivity of human platelets by activating EP2 and EP4.

Authors:  James P Smith; Elias V Haddad; Jason D Downey; Richard M Breyer; Olivier Boutaud
Journal:  Thromb Res       Date:  2010-05-08       Impact factor: 3.944

Review 2.  Regulation of platelet function by class B scavenger receptors in hyperlipidemia.

Authors:  Alejandro Zimman; Eugene A Podrez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

3.  Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia.

Authors:  Yi Ma; Mohammad Z Ashraf; Eugene A Podrez
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

Review 4.  Platelet hyperreactivity: predictive and intrinsic properties.

Authors:  Paul F Bray
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

5.  Aggregometry detects platelet hyperreactivity in healthy individuals.

Authors:  Donald L Yee; Carol W Sun; Angela L Bergeron; Jing-Fei Dong; Paul F Bray
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

6.  Hostility and platelet reactivity in individuals without a history of cardiovascular disease events.

Authors:  Daichi Shimbo; William Chaplin; Sujith Kuruvilla; Lauren Taggart Wasson; Dennis Abraham; Matthew M Burg
Journal:  Psychosom Med       Date:  2009-07-10       Impact factor: 4.312

7.  Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype.

Authors:  Eugene A Podrez; Tatiana V Byzova; Maria Febbraio; Robert G Salomon; Yi Ma; Manojkumar Valiyaveettil; Eugenia Poliakov; Mingjiang Sun; Paula J Finton; Brian R Curtis; Juhua Chen; Renliang Zhang; Roy L Silverstein; Stanley L Hazen
Journal:  Nat Med       Date:  2007-08-26       Impact factor: 53.440

8.  Evaluating the effect of donor anxiety levels and lifestyle characteristics on the activation of platelet concentrates.

Authors:  Soner Yılmaz; İbrahim Eker; Elif Elçi; Aysel Pekel; Rıza Aytaç Çetinkaya; Aytekin Ünlü; Cengizhan Açıkel; İsmail Yaşar Avcı
Journal:  Blood Res       Date:  2019-12-20

Review 9.  Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target.

Authors:  Shengjie Yang; Xinye Li; Fan Yang; Ran Zhao; Xiandu Pan; Jiaqi Liang; Li Tian; Xiaoya Li; Longtao Liu; Yanwei Xing; Min Wu
Journal:  Front Pharmacol       Date:  2019-11-19       Impact factor: 5.810

10.  Abciximab: a reappraisal of its use in coronary care.

Authors:  Marco Valgimigli; Gianluca Campo; Matteo Tebaldi; Roberto Carletti; Chiara Arcozzi; Roberto Ferrari; Gianfranco Percoco
Journal:  Biologics       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.